
Wegovy maker Novo Nordisk said surging demand for its first weight loss pill has put it on track to beat trading forecasts.
Shares in the Copenhagen-based pharmaceutical firm shot higher in early trading on Wednesday as a result.

Wegovy maker Novo Nordisk said surging demand for its first weight loss pill has put it on track to beat trading forecasts.
Shares in the Copenhagen-based pharmaceutical firm shot higher in early trading on Wednesday as a result.